The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality: A 21-Year Follow-up of 8000 Men
Abstract
For the purpose of screening individuals at high risk for coronary heart disease (CHD), serum total cholesterol (TC) of 5.2 mmol/L has been set as a value dividing “desirable” from intermediate high or elevated levels, and HDL cholesterol (HDL-C) <0.9 mmol/L has been labeled as abnormally low, implying high CHD risk. It has been conjectured that low HDL-C poses no risk in the absence of elevated LDL cholesterol or TC. To assess the risk of CHD-free men with “isolated low HDL-C,” ie, abnormally low HDL-C with desirable TC, we examined the CHD and all-cause mortality of some 8000 Israeli men aged 42 years and older during 1965 through 1986. Men with isolated low HDL-C represented one sixth of the cohort. CHD mortality among these men was 36% higher (age adjusted) than in counterparts with desirable TC, of which >0.9 mmol/L was contained in the high-density fraction. In men with TC>5.2 mmol/L, abnormally low HDL-C was associated with a virtually identical CHD mortality risk ratio, 38%. These findings persisted after adjustment for multiple CHD risk factors. The excess CHD risk associated with isolated low HDL-C appeared particularly increased in men with diabetes mellitus, whose death rate was 65% higher than in diabetics with HDL-C >0.9 mmol/L. A second subgroup result was consistent with equal CHD mortality risk among men in the “desirable” TC range, with or without low HDL-C, if systolic blood pressure was >160 mm Hg. These are post hoc findings, and hypotheses arising from these observations would require independent examination. Total mortality was not increased in men with isolated low HDL-C compared with men who had HDL-C <0.9 mmol/L and TC >5.2 mmol/L at baseline. These results indicate that an increased risk of CHD death is associated with abnormally low HDL-C for cholesterol ranges both below and above 5.2 mmol/L. For the individual, therefore, the risk is multiplied by the same amount regardless of TC. Quitting smoking, increasing physical activity, and decreasing body weight would all contribute to raise HDL-C in individuals of most or all age groups. When examined from a community perspective, the results are consistent with a relatively low population-attributable fraction among CHD-free men. This would tend to support the recommended practice of considering a TC level of 5.2 mmol/L (200 mg/dL) as a threshold for further evaluation in screened individuals without manifest CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Wood, P. D., Stefanick, M. L., Dreon, D. M., Frey-Hewitt, B., Garay, S. C., Williams, P. T., Superko, H. R., Fortmann, S. P., Albers, J. J., Vranizan, K. M., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191801 · Cited by 675
Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérum
Burstein, M., & Samaille, J. (1960) · Clinica Chimica Acta · doi:10.1016/0009-8981(60)90075-9 · Cited by 620
Fontbonne, A., Eschw�ge, E., Cambien, F., Richard, J. L., Ducimeti�re, P., Thibult, N., Warnet, J. M., Claude, J. R., & Rosselin, G. E. (1989) · Diabetologia · doi:10.1007/bf00265546 · Cited by 617
Goldbourt, U., Yaari, S., & Medalie, J. H. (2008) · Cardiology · doi:10.1159/000175862 · Cited by 304
Self-citationSocioeconomic status and coronary heart disease risk factor trends. The Minnesota Heart Survey.
Luepker, R. V., Rosamond, W. D., Murphy, R., Sprafka, J. M., Folsom, A. R., McGovern, P. G., & Blackburn, H. (1993) · Circulation · doi:10.1161/01.cir.88.5.2172 · Cited by 227
CHARACTERISTICS OF SMOKERS, NON-SMOKERS AND EX-SMOKERS AMONG 10, 000 ADULT MALES IN ISRAEL
GOLDBOURT, U., & MEDALIE, J. H. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112358 · Cited by 223
Self-citationYAARI, S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92184-x · Cited by 205
Self-citationGoldbourt, U., Behar, S., Reicher-Reiss, H., Agmon, J., Kaplinsky, E., Graft, E., Kishon, Y., Caspi, A., Weisbort, J., Mandelzweig, L., et al. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90905-r · Cited by 153
Self-citationMiller, M., Seidler, A., Kwiterovich, P. O., & Pearson, T. A. (1992) · Circulation · doi:10.1161/01.cir.86.4.1165 · Cited by 131
Alcohol-induced changes in serum lipoproteins and in their metabolism.
Taskinen, M.-R., Nikkilä, E. A., Välimäki, M., Sane, T., Kuusi, T., Kesäniemi, Y. A., & Ylikahri, R. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90614-4 · Cited by 122
Dyslipidemia and ischemic heart disease mortality among men and women with diabetes.
Goldschmid, M. G., Barrett-Connor, E. L., Edelstein, S. L., WINGARD, D. L., Cohn, B. A., & Herman, W. H. (1994) · Circulation · doi:10.1161/01.cir.89.3.991 · Cited by 121
Strisower, E. H., Adamson, G. L., & Strisower, B. (1968) · The American Journal of Medicine · doi:10.1016/0002-9343(68)90165-4 · Cited by 110
Genetic factors in coronary heart disease
(1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1130-0 · Cited by 107
Bloomfield, H. E., Robins, S. J., Iwane, M. K., Boden, W. E., Elam, M. B., Fye, C. L., Gordon, D. J., Schaefer, E. J., Schectman, G., & Wittes, J. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90708-k · Cited by 99
Groen, J. J., Medalie, J. H., Hn, N., Riss, E., Bachrach, C. A., MOUNT, F. W., & Smith, H. M. (1968) · PubMed · Cited by 66
Self-citationCholesterol and coronary heart disease mortality. A 23-year follow-up study of 9902 men in Israel.
Goldbourt, U., & Yaari, S. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.512 · Cited by 50
Self-citationBucher, K. D., Friedlander, Y., Kaplan, E. B., Namboodiri, K. K., Kark, J. D., Eisenberg, S., Stein, Y., Rifkind, B. M., & Rao, D. C. (1988) · Genetic Epidemiology · doi:10.1002/gepi.1370050103 · Cited by 38
Lipids, Apolipoproteins and Lipoproteins
Rader, D. J., & Brewer, H. B. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1130-0_6 · Cited by 27
A SAS program for evaluating person-years of risk in cohort studies
Yaari, S., & Goldbourt, U. (1989) · Computers in Biology and Medicine · doi:10.1016/0010-4825(89)90056-5 · Cited by 14
Self-citationSacks, F. M. (1992) · Circulation · doi:10.1161/01.cir.86.4.1341 · Cited by 10
Cited by
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Robins, S. J., Collins, D., Wittes, J. T., Papademetriou, V., Deedwania, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., Wexler, L. F., et al. (2001) · JAMA · doi:10.1001/jama.285.12.1585 · Cited by 921
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., Langenberg, P., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 658
Metadata
- Authors
- Goldbourt, U., Yaari, S., & Medalie, J. H.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-01
- Volume
- 17
- Issue
- 1
- Pages
- 107-113
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2047410519
- Cited by
- 391
- References
- 32
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.